Clinical features, diagnostic challenges, and management strategies in checkpoint inhibitor-related pneumonitis
Abstract: Immune checkpoint inhibitors, including cytotoxic T-lymphocyte antigen 4 (CTLA-4) and programmed cell death-1 (PD-1) inhibitors, represent an effective treatment modality for multiple malignancies. Despite the exciting clinical benefits, checkpoint inhibition is associated with a series of...
Main Author: | |
---|---|
Other Authors: | , , , , , |
Format: | article |
Language: | eng |
Published: |
2018
|
Subjects: | |
Online Access: | http://www.repositorio.ufc.br/handle/riufc/29143 |
Country: | Brazil |
Oai: | oai:www.repositorio.ufc.br:riufc/29143 |